Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
imfinzi j code | 0.42 | 0.5 | 9266 | 68 | 14 |
imfinzi | 1.6 | 0.3 | 6925 | 87 | 7 |
j | 1.56 | 0.2 | 5921 | 9 | 1 |
code | 1.41 | 0.1 | 8561 | 16 | 4 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
imfinzi j code | 0.62 | 0.2 | 9119 | 88 |
j code for imfinzi durvalumab | 1.22 | 0.3 | 2537 | 11 |
cpt code for durvalumab imfinzi | 0.81 | 0.4 | 8905 | 88 |
j code for durvalumab | 0.27 | 0.2 | 2445 | 34 |
durvalumab imfinzi package insert | 0.78 | 0.1 | 4935 | 31 |
j code for imfinzi | 0.3 | 0.6 | 324 | 18 |
imfinzi durvalumab biggest comparison | 0.34 | 0.5 | 5487 | 31 |
imfinzi durvalumab biggest cost | 1.8 | 0.6 | 2395 | 18 |
imfinzi durvalumab side effects | 0.36 | 0.9 | 7428 | 44 |
imfinzi durvalumab biggest clinical trial | 0.44 | 0.2 | 8037 | 48 |
imfinzi durvalumab biggest collaboration | 1.37 | 0.2 | 8310 | 100 |
imfinzi durvalumab biggest customer | 0.16 | 0.7 | 4903 | 97 |
cpt code for durvalumab | 0.57 | 0.6 | 3130 | 66 |
imfinzi durvalumab biggest company | 1.45 | 0.5 | 5478 | 13 |
imjudo tremelimumab + imfinzi durvalumab | 1.94 | 0.2 | 2881 | 71 |
imfinzi durvalumab biggest controversy | 0.93 | 1 | 9139 | 50 |
imfinzi durvalumab biggest competitor in cost | 0.39 | 0.5 | 2211 | 42 |
imfinzi durvalumab biggest challenge | 0.65 | 1 | 4871 | 65 |
j code for dupilumab injection | 0.01 | 0.1 | 4453 | 65 |